Tyler Janovitz

743 total citations
22 papers, 492 citations indexed

About

Tyler Janovitz is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Tyler Janovitz has authored 22 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Tyler Janovitz's work include Cancer Genomics and Diagnostics (4 papers), Virus-based gene therapy research (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Tyler Janovitz is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Virus-based gene therapy research (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). Tyler Janovitz collaborates with scholars based in United States, United Kingdom and France. Tyler Janovitz's co-authors include Gabsang Lee, Mark Tomishima, Marco Seandel, Sina Y. Rabbany, Zev Rosenwaks, Robert Benezra, Shahin Rafii, David Lyden, Lorenz Studer and Nikica Zaninović and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Journal of Virology.

In The Last Decade

Tyler Janovitz

21 papers receiving 486 citations

Peers

Countries citing papers authored by Tyler Janovitz

Since Specialization

Citations

This map shows the geographic impact of Tyler Janovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Janovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Janovitz more than expected).

Fields of papers citing papers by Tyler Janovitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyler Janovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Janovitz. The network helps show where Tyler Janovitz may publish in the future.

Co-authorship network of co-authors of Tyler Janovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Tyler Janovitz. A scholar is included among the top collaborators of Tyler Janovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyler Janovitz. Tyler Janovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results 2024 ·Histopathology ·Douglas A. Mata, Jessica Lee, Vignesh Shanmugam, (unknown), Alexa B. Schrock, Erik A. Williams, Lauren L. Ritterhouse, Richard A. Hickman, Tyler Janovitz, Nimesh R. Patel, Benjamin Kroger, Jeffrey S. Ross, Kamran Mirza, Geoffrey R. Oxnard, Jo‐Anne Vergilio, Julia A. Elvin, Jamal Benhamida, Brennan Decker, Mina L. Xu	5
2	Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers 2024 ·Frontiers in Oncology ·Douglas I. Lin, Richard S.P. Huang, Ioannis Ladas, Rachel B. Keller, Nimesh R. Patel, Sotirios Lakis, Brennan Decker, Tyler Janovitz, Douglas A. Mata, Jeffrey S. Ross, Jo‐Anne Vergilio, Julia A. Elvin, Roy S. Herbst, Philip C. Mack, Jonathan Keith Killian	1
3	FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy 2024 ·Thyroid ·Mark F Sabbagh, Tyler Janovitz, (unknown), Stephanie Siegmund, Valentina Nardi, Lori J. Wirth, Gregory W. Randolph, Jochen K. Lennerz, (unknown), Vânia Nosé, Bayan Alzumaili, William C. Faquin, Justine A. Barletta, Long P. Le, A. John Iafrate, Peter M. Sadow, Adam S. Fisch	7
4	Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers 2024 ·The Oncologist ·Natalie Y.L. Ngoi, (unknown), (unknown), Dean C. Pavlick, Gregory M. Buchold, (unknown), Vamsi Parimi, Richard S.P. Huang, Tyler Janovitz, Natalie Danziger, Mia Levy, Shubham Pant, (unknown), (unknown), Jeffrey S. Ross, Milind Javle, Jordi Rodón	13
5	Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma 2023 ·Frontiers in Oncology ·Prashanth Ashok Kumar, Serenella Serinelli, (unknown), Richard S.P. Huang, Natalie Danziger, Tyler Janovitz, (unknown), Abirami Sivapiragasam, Stephen L. Graziano, Jeffrey S. Ross	6
6	Predicting EGFR mutational status from pathology images using a real-world dataset 2023 ·Scientific Reports ·(unknown), (unknown), Daniel Duncan, Douglas I. Lin, Richard Davis, Richard S.P. Huang, Donna C. Ferguson, Tyler Janovitz, Matthew Hiemenz, (unknown), Erik Lehnert, Moran N. Cabili, Garrett M. Frampton, Priti S. Hegde, Lee A. Albacker	16
7	Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma 2022 ·Modern Pathology ·(unknown), Tyler Janovitz, (unknown), Douglas A. Mata, Meagan Montesion, Jessica Lee, Russell W. Madison, Alexa B. Schrock, Hanna Tukachinsky, Justin Allen, Rachel Erlich, Matthew Hiemenz, Richard S.P. Huang, Julia A. Elvin, Jo‐Anne Vergilio, Douglas I. Lin, Jeffrey S. Ross, Geoffrey R. Oxnard, Brennan Decker	2
8	Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups 2022 ·Gynecologic Oncology ·Douglas I. Lin, Alexander D. Fine, Natalie Danziger, Richard S.P. Huang, Douglas A. Mata, Brennan Decker, Jonathan Keith Killian, Shakti Ramkissoon, Mirna Lechpammer, Tyler Janovitz, Jeffrey S. Ross, Ethan S. Sokol, Julia A. Elvin	17
9	Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation 2022 ·The Oncologist ·Richard S.P. Huang, Julie Y. Tse, (unknown), Ryon P. Graf, Douglas I. Lin, Karthikeyan Murugesan, Matthew Hiemenz, Vamsi Parimi, Tyler Janovitz, Brennan Decker, Eric A. Severson, Mia Levy, Shakti Ramkissoon, Julia A. Elvin, Jeffrey S. Ross, Erik A. Williams	4
10	Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss). 2022 ·Journal of Clinical Oncology ·Natalie Y.L. Ngoi, (unknown), (unknown), Richard S.P. Huang, Tyler Janovitz, Natalie Danziger, Mia Levy, Shubham Pant, Milind Javle, Jeffrey S. Ross, Jordi Rodón	2
11	Genomic profile of columnar cell variant of papillary thyroid carcinoma 2021 ·Histopathology ·Tyler Janovitz, Drew F. K. Williamson, Kristine Wong, Fei Dong, Justine A. Barletta	10
12	Comprehensive molecular profiling of pleural mesothelioma according to histologic subtype. 2021 ·Journal of Clinical Oncology ·Ibiayi Dagogo‐Jack, Russell W. Madison, Douglas A. Mata, Alexa B. Schrock, Tyler Janovitz, Brennan Decker, Richard S.P. Huang, Douglas I. Lin, Jonathan Keith Killian, Shakti Ramkissoon, Ole Gjoerup, Natalie Danziger, Jeffrey M. Venstrom, Brian M. Alexander, Jeffrey S. Ross	0
13	Use of Deep Learning to Develop and Analyze Computational Hematoxylin and Eosin Staining of Prostate Core Biopsy Images for Tumor Diagnosis 2020 ·JAMA Network Open ·Aman Rana, Alarice Lowe, (unknown), (unknown), Tyler Janovitz, Annacarolina da Silva, Harrison Tsai, Vignesh Shanmugam, Akram Bayat, Pratik Shah	52
14	Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma 2018 ·Endocrine Pathology ·Tyler Janovitz, Justine A. Barletta	20
15	Parvovirus B19 integration into human CD36+ erythroid progenitor cells 2017 ·Virology ·Tyler Janovitz, Susan Wong, Neal S. Young, Thiago Y. Oliveira, Erik Falck-Pedersen	18
16	Adeno-associated virus type 2 preferentially integrates single genome copies with defined breakpoints 2014 ·Virology Journal ·Tyler Janovitz, Michel Sadelain, Erik Falck-Pedersen	8
17	High-Throughput Sequencing Reveals Principles of Adeno-Associated Virus Serotype 2 Integration 2013 ·Journal of Virology ·Tyler Janovitz, Isaac A. Klein, Thiago Y. Oliveira, Piali Mukherjee, Michel C. Nussenzweig, Michel Sadelain, Erik Falck-Pedersen	30
18	Highly Divergent Integration Profile of Adeno-Associated Virus Serotype 5 Revealed by High-Throughput Sequencing 2013 ·Journal of Virology ·Tyler Janovitz, Thiago Y. Oliveira, Michel Sadelain, Erik Falck-Pedersen	9
19	Expansion and maintenance of human embryonic stem cell–derived endothelial cells by TGFβ inhibition is Id1 dependent 2010 ·Nature Biotechnology ·Daylon James, Hyung-song Nam, Marco Seandel, Daniel J. Nolan, Tyler Janovitz, Mark Tomishima, Lorenz Studer, Gabsang Lee, David Lyden, Robert Benezra, Nikica Zaninović, Zev Rosenwaks, Sina Y. Rabbany, Shahin Rafii	235
20	Origin of Exopolyphosphatase Processivity: Fusion of an ASKHA Phosphotransferase and a Cyclic Nucleotide Phosphodiesterase Homolog 2006 ·Structure ·(unknown), (unknown), Tyler Janovitz, (unknown), Miriam S. Hasson, David Avram Sanders	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact